Cardiovascular Disease Risk Assessment – A new approach using AI
By João L. Carapinha
September 20, 2023
Artificial intelligence (AI) has a far reaching grasp. It continues to extend its reach into the healthcare space. One of the areas that its having a profound impact is in the space of early disease detection. Its now changing the way we predict and manage cardiovascular disease (CVD), which is a leading cause of mortality worldwide. Traditional risk factors such as age, sex, and family history are combined with clinical parameters like glucose and cholesterol levels to calculate risk, but these methods fall short in assessing vascular condition directly and efficiently. AI has paved the way for a more cost-effective tool for CVD risk assessment: ocular imaging. The eye’s microvascular system, particularly the retinal part, shares similarities with the brain and cardiovascular system. Research has shown a strong correlation between the retina and CVD. AI has been used to detect ocular diseases, and now, it is being applied to predict CVD from ocular images. Despite these advancements, challenges remain showing significant limitations due to population variability. The limited availability of high-quality labelled data for AI model training and validation is also major issue. There is also a need for prospective trials to validate the model’s usefulness and safety in real-world scenarios. The successful transition of AI-ocular image analysis from theory to real-world application requires addressing various challenges, including conducting cost-benefit analyses of AI models, securing funding sources, establishing information technology infrastructure, fostering social acceptance, managing clinical workflow changes, and navigating regulatory issues. In conclusion, AI in ocular imaging offers a promising tool for CVD risk assessment. However, further research and collaboration are needed to address the challenges and bring this tool to clinical application.
Explore how Health Economics and Outcomes Research (HEOR) is shaping the future of global healthcare. Read our latest article to learn more about the strategic approaches being adopted to maximise the impact of HEOR. #Healthcare #HEOR #GlobalHealthcare 🌍🩺📊 Read more here
🌍 Exciting news! 🎉 Aga Khan University and the University of Michigan are joining forces to establish a data science hub in Kenya 🇰🇪. Using AI and machine learning, they aim to improve health equity and care delivery 🏥. #DataScience #AI #HealthEquity #Collaboration
Explore the key takeaways from the CHMP February 2024 meeting. From new vaccines to innovative disease treatments, the future of healthcare is promising. Read our latest article to learn more. #CHMP2024 #HealthcareInnovation #NewDrugApprovals 🏥🔬🧬
When you partner with Syenza, it’s like a Nuclear Fusion.
Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in
health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.